Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, were recalled in the United States on Friday due to an "impurity" in the drug that poses a potential ...

Sacubitril/valsartan reduced cardiomyopathy risk by 77% in cancer patients on anthracycline chemotherapy, as shown in the SARAH trial. The trial involved 114 adults, primarily women with breast cancer ...

In the PANORAMA-HF trial, children receiving sacubitril/valsartan for their heart failure experienced clinically meaningful improvements similar to those seen in children receiving enalapril, although ...

Please provide your email address to receive an email when new articles are posted on . Presenting data from the trial during the American College of Cardiology Scientific Session, Marc Pfeffer, MD, ...

Heart failure patients unable to reach the target dose of angiotensin receptor/neprilysin inhibitor (ARNI) therapy still reaped gains in health status a year later, according to a post hoc analysis of ...

"In conclusion, adjuvant treatment for early breast cancer is associated with a reduction in left ventricular ejection fraction that was not significantly attenuated by sacubitril-valsartan," the ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. AMLODIPINE/VALSARTAN NOVARTIS contains the active ingredients ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. AMLODIPINE/VALSARTAN/HCT NOVARTIS contains the active ingredients ...